Cunningham, MJ; Bock, HA; Serrano, IC; Bechand, B; Vidyadhara, DJ; Bonniwell, EM; Lankri, D; Duggan, P; Nazarova, AL; Cao, AB; Calkins, MM; Khirsariya, P; Hwu, C; Katritch, V; Chandra, SS; McCorvy, JD; Sames, D. Pharmacological mechanism of the non-hallucinogenic 5-HT2A agonist Ariadne and analogs. ACS Chem. Neurosci., 15 Dec 2022, n/a. 15.3 MB. https://doi.org/10.1021/acschemneuro.2c00597 #37 MS,NMR,other
4-Butoxy-3,5-dimethoxyphenethylamine · B · Buscaline
2,4-Diethoxy-5-methoxyamphetamine · EEM
2,5-Diethoxy-4-methoxyamphetamine · EME
4,5-Diethoxy-2-methoxyamphetamine · MEE
2,5-Dimethoxy-4-propoxyamphetamine · MPM
4-(1-Hydroxypropyl)-2,5-dimethoxyamphetamine · HO-DOPR · Hydroxy-DOPR
4-Isopropoxy-2,5-dimethoxyamphetamine · MIPM
3,5-Dimethoxy-4-propoxyamphetamine · 3C-P
3C-IP · 4-Isopropoxy-3,5-dimethoxyamphetamine
2,5-Dimethoxy-4-butoxyphenethylamine · 2C-O-19
β-HO-2,5-DMIPA · β-Hydroxy-N-isopropyl-2,5-dimethoxyamphetamine
β-HO-N-Me-2,5-DEA · β-Hydroxy-2,5-diethoxymethamphetamine
2,3,4-Triethoxyphenethylamine · I-TRIS
4C-HE · α-Ethyl-4-(1-hydroxyethyl)-2,5-dimethoxyphenethylamine
N,N-Dimethyl-2,4,5-trimethoxyamphetamine · N,N-Me-TMA-2
N-Pr-M · N-Propyl-3,4,5-trimethoxyphenethylamine
2,4,6-TRIS · 2,4,6-Triethoxyphenethylamine · ψ-EEE
4-(2-Methoxyethyl)-2,5-dimethoxyamphetamine · DOMeOEt